Toxicants which affect the male reproductive system can act indirectly via alteration of the complex hormonal control of the testes, or directly by virtue of their chemical reactivity. Both categories of agents may require metabolic biotransformation to attain activity, and the site of activation may play a significant " role in the modulation of testicular toxicity. The modes of action of 2 well known direct-acting male reproductive toxicants are discussed here. The use of a combination of in viro and in vitro systems to distinguish the site and mechanism of action of these chemicals, ethylene glycol'monomethyl ether and dinitrobenzene, is described. Because of the complexity of the reproductive process and of the interaction between gonadal and extragonadal metabolism, the use of multiple endpoints and multiple test systems can lend a greater degree of precision and confidence to our conclusions.
INTRODUC~ION
Toxicants which affect the male reproductive system can act either directly or indirectly, and each class of toxicant may require biotransformation prior to its action. Agents which act directly do so because of their chemical reactivity. Those which act indirectly do so because of their similarity to some endogenous compound (e.g.; a hormone) or because' they cause an alteration in a physiological control mechanism important to reproduction.
For purposes of this overview, I will define an indirect reproductive toxicant as an agent which acts at a non-germ cell site (e.g., the hypothalamic-pituitary axis or the Leydig cell) to alter the hormonal control of the testis and thus alter reproduction. In contrast, an agent which affects the testis without endocrine mediation will be classified as a direct reproductive toxicant. It is upon this latter category of agents that the discussion will focus, whh particular emphasis on the role of gonadal and extra-go-nadal metabolism in modulating testicular toxicity. The former category, indirect-acting toxicants, is discussed in detail in a companion article in this volume (Chapin and Williams, pp. 446-45 1).
The site of biotransformation of direct-acting compounds may determine the extent of their testicular toxicity. Highly reactive intermediates produced in the liver are not likely to reach the testes in significant concentration because of their short biological half lives (25). Conversely, less reactive metabolic products of hepatic metabolism may attain significant concentrations in the testes and, presumably, be further metabolized to more toxic forms. The testes contain measurable amounts of cytochrome P450, mixed-function oxidases, epoxide hydrases, aryl hydrocarbon hydrolases and the various transferases necessary for the biotransformation of many exogenous compounds (7,14), although these enzymes and cofactors are often present at only a fraction of their concentration in the liver. Nonetheless, these enzymatic activities are'present in close proximity to the germ cells and may, therefore, be of particular importance in the biotransformation of testicular toxicants. In fact, the interaction between gonadal activation and hepatic.detoxification of xenobiotics likely plays a significant role in the . modulation of testicular toxicity. Because of the complex nature of this interaction, it is often necessary to use a combination of in viro and in vitro approaches to distinguish the site and mechanism of biotransformation and the mechanism of action of testicular toxicants. The combination of such studies is illustrated below for two well known reproductive toxicants.
.
ETHYLENE GLYCOL MONOhfETHYL ETHER
The glycol ethers are used extensively as solvents in the chemical and food industries and many of them are both developmental and male reproductive toxicants. Ethylene glycol monomethyl ether (2-. methoxyethanol, ME) is a well characterized testicular toxicant in rats and several other species (9, 20, 24) , and is also a known developmental toxicant in a number of species (for review, see 13). In the rat, the first evidence of testicular damage following ME treatment is observed 24 hr after a single dose; the lesion appears to be confined to late stage pachytene spermatocytes (9) . Continued dosing results in progressive depletion of spermatocytes, as well as the maturation depletion of the early spermatid population. In agreement with these observations, Chapin et a1 (3) reported a profound decrease in fertility in male rats treated for 5 days with ME, which is most notable 5 weeks after dosing. Using the spermatogenic timetable developed by Leblond and Clermont (17) , one can calculate that sperm fertilizing ova during the fifth week after exposure would have been exposed to ME as pachytene spermatocytes, the same stage observed to be depleted in the histological studies.
.The monoalkyl glycol ethers are oxidized by alcohol and aldehyde dehydrogenases to the corresponding alkoxyacetic acids. In the case of ME, the parent compound is oxidized first by alcohol dehydrogenase to methoxyacetaldehyde and then by aldehyde dehydrogenase to 2-methoxyacetic acid (MAA), the major metabolite which is excreted in the urine as a glycine conjugate (23). Metabolism of ME to MAA is apparently required for the expression of the reproductive toxicity of the compound in the male and female (23).
Zit vivo MAA has very similar toxicological properties to the parent compound (21). An equimolar dose of MAA induces testicular damage of equivalent severity to that induced by ME itself (9), suggesting that MAA is the active metabolite and testicular toxicant in vivo. Moss et a1 (23) reported that pretreatment ofmale rats with pyrazole, an inhibitor of alcohol dehydrogenase, could both prevent the metabolism of ME in vivo and protect against MEinduced testicular damage, 'further supporting the notion that metabolism of ME is a necessary ante-cedent of toxicity. However, these in vivo studies did not answer the question of where metabolism of ME occurs: In the-testes or elsewhere? 111 vitro studies have somewhat clarified the situation. Gray et a1 (1.1) used primary mixed cultures of Sertoli and germ cells to study the toxicity of ME and its metabolites. Toxicity was assessed by morphological changes in the cultured cells and by the detachment of germ cells from the Sertoli cell layer to which they were attached (the "popoff' assay). They reported that whereas ME itselfand the glycine conjugate of MAA were apparently non-toxic in vitro, MAA caused degeneration of the pachytene and dividing spermatocytes, the target cell type of the parent compound in vivo. Furthermore, analysis of the culture media from ME-treated cultures provided no evidence for the conversion of ME to MAA in vitro. Thus, their results demonstrate the necessity for metabolism to mediate ME-related testicular toxicity and suggest that such metabolism d6es not occur in the testis itself.
Similar in vivo and in vitro studies have led to the conclusion that MAA is also the proximate active metabolite which mediates the developmental toxicity of ME (29, 33) . Moreover, extensive studies by Welsch and coworkers (32) have shown that the concurrent or delayed administration of simple physiological compounds such as formate, acetate and glucose can ameliorate the incidence of MEinduced digit malformations in mice. Based on their observations, these investigators suggested that MAA was further metabolized and might be incorporated into products which are ultimately responsible for abnormal differentiation in the embryo. They suggested that the common link for the efficacy of the attenuators of the developmental toxicity was likely the 1 -carbon moiety oxidation pathway that involves tetrahydrofolic acid as a catalyst of 1-carbon transfer into purines, and that MAA's inclusion in that pathway might interfere with DNA synthesis and, thus, normal differentiation and development of the embryo.
We recently conducted a series of experiments to determine if these same simple compounds could attenuate the testicular toxicity of ME when administered concurrently. A similar response would suggest that similar mechanisms of action are responsible for both the developmental and the reproductive toxicity of ME. Male rats received a single oral dose of ME and, at the same time, received a single oral dose of the simple compounds found to be effective attenuators of ME-induced developmental toxicity (serine, sarcosine, acetate, glycine, and D-glucose) (1 9). Endpoints examined were either histopathological changes in the testes 1 and 23 days post-dosing or the rate of daily sperm pro-WORKING TOXICOLOGIC PATHOLOGY duction (DSP) 23 days after treatment. With the exception of glucose, all the compounds tested were effective in protecting against ME-induced alterations in DSP, and, interestingly, the relative potency rank order for the attenuation was the same for both reproductive and developmental toxicity of ME (serine > sarcosine B acetate = glycine). What is the significance of these observations in terms of the possible mechanism of action of ME? Recall that Welsch et a1 (32) suggested that ME might ultimately cause embryotoxicity by interfering with the purine base supply and, thereby, DNA synthesis in the embryo. This is not a likely mechanism for the testicular toxicity of ME, since pachytene spermatocytes (the target cell stage) are not undergoing DNA synthesis during spermatogenesis. However, this late-stage primary spermatocyte is undergoing a period of maximal meiotic RNA synthesis (15, 16, 22) and might, therefore, be particularly susceptible to alterations in the supply of purine bases. Of course, the developing embryo is also in a period of intense RNA synthesis, so this same mechanism, rather than interference with DNA synthesis, might also account for the developmental toxicity of ME.
To conclude, using a combination of in vivo and ilz vitro techniques, it has been possible to show that ME must be metabolized to exert its toxic effect on the testes, that such metabolism probably does not occur in the testes and that ME may act via its interference with the supply of purine bases and RNA synthesis in the target cell. The ability of in vitro assays, when carefully examined in the context of the in vivo observations, to "dissect" the mode and mechanism of action of a testicular toxicant is apparent. DINITROBENZENE Dinitrobenzene (DNB), is a nitroaromatic compound used mainly as an intermediate in the syn-' thesis of plastics and dyes. Commercial DNB is a mixture of the 1,2-, 1,3-and 1,4-isomers, with 1,3-DNB predominating. All 3 isomers induce methemoglobinemia in rats; 1,4-DNB is the most potent (8, 12) . 1,3-DNB is also a reproductive toxicant in male rats, causing testicular atrophy and decreases in sperm quality and fertility (4, 18) . After a single oral or ip dose, the 1,3-DNB-induced testicular lesion is limited to stages VIII to XI11 of the spermatogenic cycle (2, 6) ; it is characterized by Sertoli cell damage and degeneration of pachytene spermatocytes in these stages (2, 6) . Ultrastructural examination revealed that the Sertoli cell is the initial target for the toxic effect of 1,3-DNB and that germ cell damage is secondary to the Sertoli cell toxicity (2) . Cell culture studies in mixed germ cell-Sertoli cell cultures confirmed these observations (10) . Isomer comparison studies have shown that only the 1,3-isomer is a testicular toxicant and that I neither 1,2-nor 1,4-DNB induces testicular damage iit viw (2, 6) . .
Metabolic differences may account for the observed isomeric specificity of the testicular effect of the DNBs. The isomers have 2 major routes of metabolism both in vitro and in vivo (5, 26) . Conjugation with glutathione accounts for .a significant portion of the 1,2-or 1,4-DNB dose, but not of the 1,3-DNB dose. In contrast, nitro group reduction occurs with all 3 isomers, but is apparently the only metabolic route followed by 1,3-DNB (26) . Accordingly, the major reduced metabolites of the 3 isomers were tested for their testicular toxicity in vivo and in vitro. The corresponding nitroaniline (NA) metabolites (2-, 3-and 4-NA) of the'3 DNB isomers were found to be without toxic effect in the testes of rats in viw (6) . Two other reduced metabolites of 1,3-DNB (1,3-diaminobenzene and 1,3-nitroacetanilide) are also not testicular toxicants hhen tested under the same conditions as the parent compound. These data suggest that either the parent compound or some transient intermediate metabolite (e.g., 3-nitrosoniirobenzene) is the toxic form.
Recently, disposition studies have shown that a significantly larger proportion (up to 5-fold) of the initial dose of radiolabeled 1,3-DNB than of the other 2 isomers is present in the testes 24 hr after a single oral treatment (27) . The only nitroreduced metabolites in the testes were 3-NA and 1,3-nitroacetanilide (metabolites of 1,3-DNB), but glutathioneconjugated metabolites of all 3 isomers were present.
The isomers are also metabolized differently in vitro. Metabolism of 1,2-and 1,4-DNB is relatively rapid and complete in testicular S-9 fractions, reaching a maximum in about 15 min, with only 40% and lo%, respectively, of the parent compound'remaining after that time period (27) . Major metabolites of each in this system were the corresponding nitroanilines and glutathione conjugates. In contrast, only 10% of 1,3-DNB had been metabolized after 6 hr incubation in this system, with 3-NA the only metabolite detected. Foster et a1 (10) examined the metabolism of 1,3-DNB in primary cultures of rat testes. They reported that approximately 3% of the added 1,3-DNB was metabolized after 24 hr in culture. The only metabolites detected were 3-NA and 3-nitroacetanilide, neither of which was toxic in the cultures and it was therefore suggested that either 1,3-DNB or some reactive nitroreduced me-. tabolite produced in sitzr was the likely testicular toxicant (10). .
We have conducted similar metabolic studies with all 3 isomers of DNB using a seminiferous tubule segment culture system (28, 3 l), which is described in detail in an earlier publication (1) . We first examined the metabolism of the 3 isomers in spermatogenic stages (VIII to X) known to be sensitive to the toxic effect of 1,3-DNB (Working, unpublished). Metabolism of 1,2-and 1,4-DNB reached a maximum (56 and 84%, respectively) by 6 hr of incubation. Nitroreduced and glutathione-conjugated metabolites of both isomers were detected. In contrast, no detectable metabolism of 1,3-DNB occurred after up to 24 hr of culture.
We also assessed the toxicity of the parent DNBs and various reduced metabolites in these cultures. Toxicity was recognizable as changes in pachytene . spermatocyte morphology when live tubule squashes were viewed by phase contrast microscopy (Working, unpublished). Of the 3 isomers, only 1,3-DNB was a toxicant at concentrations equivalent to those measured in vivo after a single oral dose (27).
Both 1,2-and 1,4-DNB also had toxic effects, but only at more than 50 times their peak testicular concentration in vivo. No nitroreduced metabolite, including 3-nitrosonitrobenzeneY was toxic in vitro at physiologically relevant concentrations, suggesting that metabolism is not a prerequisite of 1,3-DNB testicular toxicity.
From this combination of in vivo and in vitro studies, we were able to conclude that the 1,3-DNB parent compound is the likely toxic form in the testis in vivo. It seems probable that neither 1,2-nor 1,4-DNB attains a toxic concentration in the testes in vivo because of their comparatively more complete metabolism by glutathione conjugation and nitroreduction at extragonadal sites (5, 26) .
CONCLUSIONS
The 2 cases discussed'above illustrate the use of a combination of in vivo and in vitro studies to dis-' tinguish the site and mechanism of biotransformation of reproductive toxicants. Because of the complexity of the reproductive process and of the interaction between gonadal and extragonadal metabolism, the use of multiple endpoints and multiple test systems can lend a greater degree of precision and confidence to our conclusions.
